CINECA IRIS Institutional Research Information System

GENAZZANI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 67.545
AS - Asia 32.512
EU - Europa 22.840
SA - Sud America 3.538
AF - Africa 419
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 34
AN - Antartide 1
Totale 126.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 65.644
CN - Cina 10.581
SG - Singapore 9.741
IT - Italia 6.571
HK - Hong Kong 4.831
BR - Brasile 3.033
SE - Svezia 3.010
KR - Corea 2.476
BG - Bulgaria 2.287
UA - Ucraina 2.178
VN - Vietnam 2.000
PL - Polonia 1.834
CA - Canada 1.643
DE - Germania 1.401
TR - Turchia 1.377
FR - Francia 1.124
FI - Finlandia 1.023
RU - Federazione Russa 976
GB - Regno Unito 917
CH - Svizzera 884
IN - India 300
JP - Giappone 241
BD - Bangladesh 168
AR - Argentina 155
BE - Belgio 138
IQ - Iraq 130
ID - Indonesia 125
MX - Messico 104
NL - Olanda 90
EC - Ecuador 86
ZA - Sudafrica 81
PK - Pakistan 70
VE - Venezuela 70
ES - Italia 69
SA - Arabia Saudita 67
CO - Colombia 58
CI - Costa d'Avorio 57
MA - Marocco 57
UZ - Uzbekistan 57
PH - Filippine 42
IE - Irlanda 41
AU - Australia 39
CL - Cile 39
GR - Grecia 37
KE - Kenya 37
NP - Nepal 34
TN - Tunisia 34
JO - Giordania 31
RO - Romania 31
EG - Egitto 30
IL - Israele 30
UY - Uruguay 30
MY - Malesia 29
PE - Perù 29
BJ - Benin 28
CZ - Repubblica Ceca 28
EU - Europa 28
JM - Giamaica 28
PY - Paraguay 27
TT - Trinidad e Tobago 27
HU - Ungheria 26
AT - Austria 24
AE - Emirati Arabi Uniti 22
PT - Portogallo 22
KZ - Kazakistan 18
LB - Libano 18
AZ - Azerbaigian 17
DK - Danimarca 17
SN - Senegal 17
HN - Honduras 16
AL - Albania 15
CR - Costa Rica 15
DZ - Algeria 15
LT - Lituania 15
NZ - Nuova Zelanda 13
RS - Serbia 13
HR - Croazia 12
ET - Etiopia 11
OM - Oman 11
TH - Thailandia 11
NG - Nigeria 10
NI - Nicaragua 10
PS - Palestinian Territory 10
TW - Taiwan 10
AO - Angola 9
BO - Bolivia 9
DO - Repubblica Dominicana 8
EE - Estonia 8
SV - El Salvador 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
BS - Bahamas 7
NO - Norvegia 7
PR - Porto Rico 7
SK - Slovacchia (Repubblica Slovacca) 7
BB - Barbados 6
CY - Cipro 6
IR - Iran 6
XK - ???statistics.table.value.countryCode.XK??? 6
CG - Congo 5
Totale 126.814
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.162
Ashburn 6.056
Ann Arbor 5.939
Singapore 5.824
Houston 5.473
Fairfield 5.347
Hong Kong 4.784
Chandler 3.680
Hefei 3.246
Milan 3.114
San Jose 2.859
Jacksonville 2.855
Dallas 2.841
Seoul 2.451
Seattle 2.409
Sofia 2.284
Wilmington 2.026
Cambridge 1.869
Ottawa 1.499
Shanghai 1.479
Beijing 1.327
New York 1.289
Santa Clara 1.054
Nanjing 905
Boardman 894
Izmir 873
Bern 862
Princeton 849
Lawrence 841
Medford 809
Lauterbourg 732
Des Moines 630
Los Angeles 520
The Dalles 510
Jüchen 504
Dearborn 498
Columbus 448
Council Bluffs 441
Ho Chi Minh City 420
Istanbul 408
Buffalo 389
Dong Ket 386
Nanchang 330
Hanoi 296
San Diego 239
São Paulo 225
Tokyo 219
Falls Church 212
Rome 208
Kunming 194
Helsinki 182
Shenyang 167
Redondo Beach 162
Boulder 160
Changsha 141
Hebei 137
Brussels 135
Marseille 135
Ogden 129
Tianjin 122
Lancaster 115
Norwalk 115
Frankfurt am Main 108
Rio de Janeiro 100
Jiaxing 99
Jakarta 93
Redwood City 93
Orange 86
Guangzhou 81
Verona 79
Belo Horizonte 77
Pune 75
Florence 74
London 74
Washington 72
Munich 71
Hangzhou 70
Düsseldorf 64
Baghdad 59
Brasília 58
Abidjan 57
Curitiba 56
Serra 53
Jinan 51
Tashkent 51
Da Nang 50
San Francisco 49
Fuzhou 45
Lanzhou 45
Phoenix 45
Chicago 44
Haiphong 42
Warsaw 42
Campinas 41
Edinburgh 41
Orem 40
Atlanta 39
Zhengzhou 39
Changchun 38
Dhaka 38
Totale 95.748
Salva come PNG Salva come JPEG
Nome #
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism 2.006
Neuroendocrine Changes during Menopausal Transition 607
Menopause, Hormone Replacement Therapy (HRT) and Obesity 445
Optimizing quality of life through sex steroids by their effects on neurotransmitters 407
Oral dehydroepiandrosterone restores β-endorphin response to OGTT in early and late postmenopause 259
Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. 256
Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. 256
Clinical and endocrinological investigations on superovulation induced in heifers by human menopausal gonadotrophin. 248
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 248
Secretion pattern of endogenous opioids in chronic schizophrenia. 246
Plasma and CSF endorphin levels in primary and symptomatic headaches. 245
Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause. 244
Oestradiol/progesterone imbalance and the premenstrual syndrome. 239
Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. 236
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. 235
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. 233
Domperidone in defective and insufficient lactation. 232
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 231
Opioids and testicular activity in the frog, Rana esculenta. 231
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. 229
Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men. 229
Pituitary response to hypoglycemia in pituitary diseases. 228
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. 226
Plasma opioids in the first hours of life. 225
Cytogenetic study on 282 patients with suspected chromosomal aberration. 225
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. 225
Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. 225
Beta-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. 224
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine. 223
Pregnancy diagnosis in cattle by a rapid and highly reliable method for progesterone determination in milk. 223
Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women 223
Progressive impairment of CSF beta-EP levels in migraine sufferers. 222
Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. 222
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. 220
Absent B-endorphin response to clonidine in obese children. 220
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. 219
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. 219
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. 219
Gonadal steroid modulation of naloxone-induced LH secretion in the rat. 218
Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty. 217
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. 217
Lack of beta-endorphin plasma level rise in oxytocin-induced labor. 217
Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. 217
Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. 217
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: changes during the menstrual cycle. 216
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. 216
Fetal intermediate lobe is stimulated by parturition 216
Menstrual-related mood changes in patients with oligomenorrhea. 216
The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height 216
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia 215
Nomifensine: diagnostic test in hyperprolactinemic states. 214
Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. 214
Endorphin patterns within the headache spectrum disorders. 214
Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. 214
Expression of proopiomelanocortin-related peptides in human follicular fluid. 214
Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome. 213
Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea. 213
Effect of estetrol administration on brain and serum allopregnanolone in intact and ovariectomized rats 213
Opioid plasma levels during labour. 212
Hypothalamus-pituitary-adrenal axis of heroin addicts. 212
Pituitary proopiomelanocortin peptides in mental disorders. 212
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. 212
A review of the cardiovascular and breast actions of drospirenone in preclinical studies. 212
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. 211
The association of menstrual migraine with the premenstrual syndrome. 211
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome 211
Plasma thyrotrophin levels during pregnancy. 210
Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. 210
Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. 210
Presence of acetylated and shortened endorphins in human fetal pituitary gland. 210
Contraception in older woman. 210
Beta-lipotropin and beta-endorphin in physiological and surgical menopause. 209
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. 209
The HRT misuse and osteoporosis epidemic: a possible future scenario 209
Endothelium and estrogen receptors 207
Factors associated with pain complaints in a clinical sample of postmenopausal women. 205
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 205
Adrenal and gonadal steroids in girls during sexual maturation. 204
Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis. 204
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. 204
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 204
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. 204
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. 204
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 204
Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone. 202
Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles. 202
Neuroendocrine evaluation of central opiate activity in primary headache disorders 201
Abnormal concentration of maternal serum activin-A in gestational diseases. 201
Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development. 201
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. 201
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells 201
Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty. 200
Endogenous opioid peptides in uterine fluid. 200
Nomifensine-induced pregnancy in a hyperprolactinemic woman. 199
Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. 199
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. 199
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists. 199
Episodic release of prolactin in women with weight loss-related amenorrhea. 198
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome 198
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. 197
Totale 24.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 324.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 324.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.772 72 341 137 741 1.943 1.361 180 386 623 226 304 2.458
2022/20238.366 1.193 702 344 799 1.231 1.315 100 761 1.247 46 527 101
2023/202411.138 1.944 1.174 1.512 628 1.315 1.403 106 300 176 1.867 85 628
2024/202522.240 47 921 141 1.491 1.143 1.613 1.641 1.529 2.458 3.377 3.816 4.063
2025/202625.460 2.449 4.498 4.275 1.547 1.583 2.394 4.096 933 993 1.609 601 482
2026/2027182 182 0 0 0 0 0 0 0 0 0 0 0
Totale 127.397